{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:32:30Z","timestamp":1790793150883,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neuro.2020.03.015","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T19:46:30Z","timestamp":1585597590000},"page":"20-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Use of new psychoactive substances to mimic prescription drugs: The trend in France"],"prefix":"10.1016","volume":"79","author":[{"given":"Anne","family":"Batisse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Eiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Peyriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Djezzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2020.03.015_bib0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/15563650.2016.1211288","article-title":"Adverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project","volume":"54","author":"B\u00e4ckberg","year":"2016","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.neuro.2020.03.015_bib0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.therap.2016.04.003","article-title":"R\u00e9seau fran\u00e7ais des centres d\u2019addictovigilance. Use of psychostimulants in a sexual context: analysis of cases reported to the French network of Addictovigilance Centers","volume":"71","author":"Batisse","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.neuro.2020.03.015_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.therap.2018.07.007","article-title":"From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)","volume":"74","author":"Baumevieille","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.neuro.2020.03.015_bib0020","first-page":"3","article-title":"Use of cognitive enhancers: methylphenidate and analogs","volume":"23","author":"Carlier","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.neuro.2020.03.015_bib0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/15563650.2018.1510502","article-title":"Designer benzodiazepines: a report of exposures recorded in the national poison data system, 2014-2017","volume":"57","author":"Carpenter","year":"2019","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.neuro.2020.03.015_bib0030","first-page":"S0955","article-title":"Nonmedical prescription psychiatric drug use and the darknet: a cryptomarket analysis","author":"Cunliffe","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.neuro.2020.03.015_bib0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3109\/15563650.2015.1088157","article-title":"Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN)","volume":"53","author":"Dines","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuro.2020.03.015_bib0040","series-title":"Comit\u00e9 Technique Des Centres d\u2019\u00c9valuation Et d\u2019Information Sur La Pharmacod\u00e9pendance-addictovigilance \u2014 CT022019023","author":"DRAMES 2017 data","year":"2017"},{"key":"10.1016\/j.neuro.2020.03.015_bib0045","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/fcp.12395","article-title":"Peyriere H; French Network of Addictovigilance Centers. Ephenidine, diphenidine, and methoxphenidine complications reported to the French Addictovigilance Network","volume":"32","author":"Eiden","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuro.2020.03.015_bib0050","series-title":"Health Responses to New Psychoactive Substances","author":"EMCDDA","year":"2016"},{"key":"10.1016\/j.neuro.2020.03.015_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00406-014-0537-1","article-title":"Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects","volume":"264","author":"Franke","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuro.2020.03.015_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/10826084.2019.1654516","article-title":"The availability of modafinil and methylphenidate purchased from the internet in the United Kingdom without a prescription","volume":"55","author":"Hockenhull","year":"2020","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.neuro.2020.03.015_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2515\/therapie\/2015009","article-title":"Signal identification in addictovigilance: the functioning of the french system","volume":"70","author":"Jouanjus","year":"2015","journal-title":"Therapie"},{"key":"10.1016\/j.neuro.2020.03.015_bib0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.forsciint.2019.02.021","article-title":"Death cases involving certain new psychoactive substances: a review of the literature","volume":"25","author":"Kraemer","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuro.2020.03.015_bib0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/clpt.1982.222","article-title":"Phenmetrazine: an obsolete problem drug","volume":"32","author":"Mellar","year":"1982","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuro.2020.03.015_bib0080","series-title":". D\u00e9cret no. 99\u2013249 Du 31 Mars 1999 Relatif Aux Substances V\u00e9n\u00e9neuses Et \u00e0 l\u2019Organisation De La Pharmacodependance","author":"Minist\u00e8re de l\u2019Emploi et de la Solidarit\u00e9","year":"1999"},{"key":"10.1016\/j.neuro.2020.03.015_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drugpo.2018.08.005","article-title":"#Drugsforsale: an exploration of the use of social media and encrypted messaging apps to supply and access drugs","volume":"63","author":"Moyle","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.neuro.2020.03.015_bib0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.forsciint.2015.08.008","article-title":"A review of ethylphenidate in deaths in east and west Scotland","volume":"257","author":"Parks","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuro.2020.03.015_bib0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.neuro.2020.03.015_bib0100","first-page":"40","article-title":"Drames (D\u00e9c\u00e8s en relation avec l\u2019abus de m\u00e9dicaments et de substances) : outil d\u2019identification des d\u00e9c\u00e8s li\u00e9s \u00e0 la drogue en France","author":"Richard","year":"2010","journal-title":"BEH"},{"key":"10.1016\/j.neuro.2020.03.015_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/JCP.0000000000001167","article-title":"Serious complications associated with the injection of ethylphenidate: 2 case reports","volume":"40","author":"Roy","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuro.2020.03.015_bib0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neuro.2020.03.015_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugpo.2017.11.003","article-title":"The diverse reasons for using Novel Psychoactive Substances\u2014a qualitative study of the users\u2019 own perspectives","volume":"52","author":"Soussan","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.neuro.2020.03.015_bib0120","series-title":"Market Analysis of Synthetic Drugs. Amphetamine-type Stimulants, New Psychoactive Substances","article-title":"Sales No. E.17.XI.6","author":"United Nations Office on Drugs and Crime","year":"2017"},{"issue":"73","key":"10.1016\/j.neuro.2020.03.015_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of new psychoactive substances-designer benzodiazepines","volume":"23","author":"Zawilska","year":"2019","journal-title":"Neurotoxicology."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X20300577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X20300577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:20:01Z","timestamp":1758982801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X20300577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"alternative-id":["S0161813X20300577"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2020.03.015","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of new psychoactive substances to mimic prescription drugs: The trend in France","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2020.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}